Tender Offer - CG Oncology, Inc.

Form Type: ARS

Filing Date: 2025-04-25

Corporate Action: Tender-offer

Type: New

Accession Number: 000095017025058345

Filing Summary: On April 25, 2025, CG Oncology, Inc. announced a tender offer for its outstanding shares at a price of $10.50 per share. This tender offer is being conducted to return value to shareholders and facilitate further strategic initiatives. The company intends to repurchase up to 1 million shares in this offering and has set a deadline for acceptance by May 30, 2025. Shareholders are encouraged to consider this opportunity as it is part of the company's commitment to maximizing shareholder value. In conjunction with the tender offer, CG Oncology has appointed a financial advisor to manage the process and has filed the appropriate documentation with the SEC.